Comparison of the diuretic effect of furosemide mixed with human albumin or fresh frozen plasma for patients with hypoalbuminemia in the intensive care unit

Journal of Nephrology

Volumn 19, Issue 5, 2006, Pages 621-627

  Hsu, Chien Wei ^a   Lin, Shoa Lin ^a   Sun, Shu Fen ^a   Chu, Kuo An ^a   Chung, Hsiao Min ^a   Chang, Hsueh Wen ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Albumin; Diuresis; Fresh frozen plasma; Furosemide; Hypoalbuminemia; Natriuresis

Indexed keywords

FRESH FROZEN PLASMA; FUROSEMIDE; HUMAN ALBUMIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DRUG RESISTANCE; FEMALE; HUMAN; HYPERVOLEMIA; HYPOALBUMINEMIA; INTENSIVE CARE UNIT; MALE; NATRIURESIS; RANDOMIZED CONTROLLED TRIAL; SODIUM EXCRETION; SODIUM URINE LEVEL; URINE VOLUME;

ADULT; CREATININE; CROSS-OVER STUDIES; DIURESIS; DIURETICS; DRUG RESISTANCE; FEMALE; FUROSEMIDE; HUMANS; HYPOALBUMINEMIA; INTENSIVE CARE UNITS; MALE; PLASMA; PROSPECTIVE STUDIES; SERUM ALBUMIN; SINGLE-BLIND METHOD; SODIUM; TIME FACTORS;

EID: 33947192366     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sjöström PA, Kron BG, Odlind BG. Determinants of furosemide delivery to its site of action. Clin Nephrol 1995; 43: 38-41.
2. Green TP, Mirkin LB. Mechanism of resistance to furosemide diuresis in children with edema. Pediatr Res 1979; 13: 369.
3. Brater DC. Resistance to diuretics: emphasis on a pharmacological perspective. Drugs 1981; 22: 477-94.
4. Davison AM, Lambie AT, Verth AH, Cash JD. Salt-poor human albumin in management of nephrotic syndrome. Br Med J 1974; 1: 481-4.
5. Weiss RA, Schoeneman M, Greifer I. Treatment of seveŕe nephrotic edema with albumin and furosemide. N Y State J Med 1984; 84: 384-6.
6. Rabelink TJ, Bijlsma JA, Koomans HA. Iso-osmotic volume expansion in the nephrotic syndrome. Clin Sci 1993; 84: 627-32.
7. Pacifici GM, Vian A, Schulz HU, Frercks HJ. Plasma protein binding of furosemide in the elderly. Eur J Clin Pharmacol 1987; 32: 199-202.
8. Pacifici GM, Viani A, Taddeucci-Brunelli G. Serum protein binding of furosemide in newborn infants and children. Dev Pharmacol Ther 1987; 10: 413-21.
9. Hammarlund MM, Paalzow LK. Dose-dependent pharmacokinetics of furosemide in the rat. Biopharm Drug Dispos 1982; 3: 345-59.
10. Andreasen F, Mikkelsen E. Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. Eur J Clin Pharmacol 1977; 12: 15-22.
11. Andreason F, Hanson HE, Mikkelsen E. Pharmacokinetics of furosemide in anephric patients and in normal subjects. Eur J Clin Pharmacol 1978; 13: 41-8.
12. Verbeeck RK, Patrwardhan RV, Villeneuve JP, Wilkinson GR, Branch RA. Furosemide disposition in cirrhosis. Clin Pharmacol Ther 1982; 31: 719-25.
13. Rane A, Villeneuve JP, Stone WJ, Nies AS, Wilkinson GR, Branch RA. Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia. Clin Pharmacol Ther 1978; 24: 199-207.
14. Allgulander C, Beermann B, Sjogren A. Furosemide pharmacokinetics in patients with liver disease. Clin Pharmacokinet 1980; 5: 570-5.
15. Inoue M, Okajimak, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S, Morino Y. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 1987; 32: 198-203.
16. Rybak LP, Whitworth C, Scott V. Furosemide ototoxicity is enhanced in analbuminemic rats. Arch Otolaryngol Head Neck Surg 1993; 119: 758-61.
17. Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, La Villa G, Laffi G. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999; 30: 639-45.
18. O'Shaughnessy DF, Atterbury C, Maggs PB, Murphy M, Thomas D, Yates S, Williamson LM. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
19. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trial. Br J Haematol 2004; 126: 139-152.
20. Brater DC, Anderson A, Brown-Cartwright D. Response to furosemide in chronic renal insufficiency:rationale for limited dose. Clin Pharmacol Ther 1986; 40: 134-9.
21. Brater DC, Chennavasin P, Seiwell R. Furosemide in patients with heart failure: shift in dose-response curves. Clin Pharmacol Ther 1980; 28: 182-6.
22. Kerremans AL, Tan Y, van Baars H, van Ginneken CA, Gribnau FW. Furosemide kinetics and dynamics in aged patients. Clin Pharmacol Ther 1983; 34: 181-9.
23. Vasko MR, Cartwright DB, Knochel JP, Nixon JV, Brater DC. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 1985; 102: 314-8.
24. Hurley DR. Infectious hazards associated with blood transfusion. Adverse Drug React Toxicol Rev 1995; 14: 157-74.
25. Elwell RJ, Spencer AP, Eisele G. Combined furosemide and human albumin treatment for diuretic-resistant edema. Ann Pharmacother 2003; 37: 695-700.